PENNON GROUP PLC (PNN) — Research Note

Executive summary

Pennon is a UK regulated water utility (South West Water, Bristol Water, SES Water, plus small non-household retail and nascent renewables) serving ~3.5m customers and operating under Ofwat's AMP8 (2025–2030) regulatory framework. Operating trajectory has deteriorated sharply over the covered period: a 2024 Brixham cryptosporidium outbreak, worsening Environmental Performance Assessment metrics (pollutions, storm overflow performance), ODI penalties, and now (October 2026) a comprehensive operational "reset" by new CEO Keith Haslett accompanied by a surprise £550m dilutive rights issue at 250p (a 35.5% discount to TERP) and a ~30% underlying dividend cut 2026-10-07 Strategic Update. The single most important point for valuation today: Pennon has reset its AMP8 capex plan up by ~£1bn to ~£3.6bn to fix an under-invested asset base, funded by rebased dividends, debt and dilutive equity — so the shares should be valued on post-raise share count and gearing, not pre-announcement capital structure.

Fair value estimate

Methodology: RCV multiple sum-of-the-parts (standard UK water comp). Group RCV at 31 March 2026 was £6,505m (Water Group); AMP8 plan targets >40% RCV growth to ~£7.9bn by March 2030 2026-10-07 Strategic Update, 2026-06-10 FY2025/26. Post rights issue: ~741.8m shares and group net debt reducing modestly toward target 55–65% water gearing / ≤70% group gearing.

• Central case: 1.0× FY2026 RCV minus pro-forma net debt (~£4.0bn after net £530m rights proceeds applied against funding needs): £6.5bn − £4.0bn = £2.5bn equity post-raise → ~335p post-rights (or equivalent ~360p on current 521.5m share count after adding rights-value-received).
• Low case: 0.9× RCV, reflecting sustained ODI penalties and regulatory risk → ~250p post-rights (~290p pre-rights basis).
• High case: 1.1× RCV plus some credit for AMP8 RCV growth → ~440p post-rights (~430p pre-rights basis).

Stated range (pence, on current 521.5m share basis to match the quoted market cap): 310p – 420p per share; midpoint ~365p.

• Implied fair-value market cap (midpoint, like-for-like): ~£1,900m
• Latest disclosed market cap: £1,701m
• Absolute upside at midpoint: ~+12%

The shares look modestly undervalued relative to RCV, but the discount is narrow once execution risk, further potential cost-change capex, and ODI penalties are factored in.

Sector context

• Sector: Utilities (Water). Correctly classified.
• Quality/growth/leverage vs. peers: Group gearing (~68% at FY26) is at the higher end of the UK water sector and has deteriorated vs. the sector median; operational KPIs (pollutions, EPA star rating) are below sector median; AMP8 totex uplift of ~40% is in line with sector averages. Overall quality profile: below in-line with regulated water peers.
• Listed peers: Severn Trent (SVT.L), United Utilities (UU.L). Both have cleaner operational records and lower-risk balance sheets, generally earning better regulatory assessments.

Investment thesis (3 bullets)

1. Post-raise balance sheet reset creates an asset-backed, inflation-linked RCV platform growing ~7% CAGR through AMP8. The £550m rights issue plus Pennon Power disposal proceeds restores gearing headroom, and Ofwat's cost-change mechanism provisionally allowed £230m additional RCV at draft determination (final due 15 Dec 2026) 2026-10-07 Rights Issue announcement.
2. Operational reset under new CEO targets ≥50% reduction in ODI penalties and 100% bathing water compliance already achieved for a fifth consecutive year — concrete evidence (pollutions −34% YoY, storm overflow spills −17% YoY in FY26) suggests the Pollution Incident Reduction Plan is working, albeit from a low base 2026-06-10 FY2025/26 results.
3. Shares now trade at ~0.95× current RCV with a c.5.5% rebased dividend yield (~18p), below long-run water-sector multiple of 1.1–1.2× RCV; if operational KPIs stabilise, re-rating optionality exists even without heroic assumptions 2026-06-10, 2026-10-07.

Key risks (3 bullets)

1. Further rights issues / covenant risk. The February 2025 rights issue (£490m) was explicitly described as sufficient to fund AMP8 — 20 months later a further £550m is being raised. Management credibility on funding adequacy is severely impaired, and Moody's rating already on negative watch; a further downgrade would raise financing costs 2026-10-07 Strategic Update, 2025-01-29 FD Acceptance announcement.
2. Continued ODI penalties and EPA downgrade risk. Net ODI penalty of ~£58m in FY26 against new tougher AMP8 targets; management now admits 4-star EPA by 2028 is "very challenging" 2026-10-07 Strategic Update. Pending DWI, Ofwat and Environment Agency actions could still result in material further penalties.
3. Regulatory political overhang. Cunliffe Review and government White Paper threaten more intrusive regulation; sector-wide investigations into sewage ongoing; limited management ability to accelerate RCV returns without regulatory agreement (not disclosed but inferred from 2026-06-10 and 2025-11-27 commentary).

Operating leverage

Pennon's operating leverage is low. Underlying revenue is set by Ofwat for five years in nominal CPIH-linked terms; costs are a mix of inflation-linked opex (~75% of operating costs scale with activity, inflation and wholesale power prices) and depreciation/finance costs (which grow mechanically with the capital programme). Even significant volume outperformance (10–20% above the regulated case) is clawed back via regulatory revenue true-ups so does not drop to shareholders. Where operating leverage DOES exist: (i) totex outperformance vs. the Final Determination can be partially retained via the sharing mechanism, delivering ~2% RORE uplift to equity returns in a successful year (as seen in Water Group FY26 totex outperformance of 2.0%); (ii) financing outperformance from index-linked debt mix can add 1–2% to RORE through an inflationary cycle (Group delivered +1.4% in FY26) 2026-06-10 FY2025/26 CFO review. The net effect: a 10% revenue surprise in a regulated utility like this would translate to perhaps 1–3% uplift in equity returns over a period, not multiples of profit. This is the opposite of what the user's "operating leverage to long-tail upside" preference targets.

Value-trap signals

• Repeated capital raises (£490m Feb 2025, now £550m Oct 2026) with each one described as "sufficient" at the time
• Rebased dividend (−30% underlying) and loss of CPIH+2% growth policy
• Statutory profits dominated by inflation-driven RCV accretion rather than cash earnings; adjusted EPS 28.3p vs. statutory EPS 19.4p and large deferred-tax moves 2026-06-10
• Repeated regulatory enforcement actions (DWI prosecution, Ofwat enforcement undertakings, EA prosecutions) with £12.9m of fines/settlements in FY26 alone
• Operational KPIs trending below sector average on key common ODIs (pollutions, EPA)
• Credit rating on negative watch

Earnings vs. expectations

• FY2023/24: Guidance set in Nov 2023 for FY24 pointed to recovery; actual outturn was a statutory loss of £9.1m (vs. FY23 loss of £8.5m) and adjusted EPS of 6.2p vs. 7.3p prior year — broadly in line but worse than suggested.
• FY2024/25: Guidance was for progressive recovery; actual was a statutory loss of £56.8m, adjusted EPS of −10.3p, and ODI penalties stepping up — a miss against the implicit recovery narrative, triggering the first (£490m) rights issue.
• FY2025/26: Guidance pointed to a return to profitability with EBITDA up ~60% YoY; delivered underlying EBITDA +55% and statutory profit of £114.4m — broadly in line financially but with substantially worse operational metrics than guided, triggering CEO change and now the second rights issue.
• Pattern: Financial guidance has been roughly met; operational guidance (ODI performance, EPA rating path, sufficiency of capital) has been repeatedly missed. Management credibility on multi-year commitments is poor.

Conviction

3 — moderate.

Anchoring factors: (i) RCV-based valuation is the standard sector methodology and both low and high scenarios bracket the current price plausibly; (ii) regulatory framework provides clear visibility on revenue trajectory and base return; (iii) the balance sheet is now cleaner post-rights.

Limiting factors: (i) ongoing legal and regulatory proceedings (DWI, EA, Ofwat enforcement, Cunliffe Review implementation) could produce further material downside not yet in numbers; (ii) history of successive "sufficient" capital raises damages confidence that the £550m fully resolves funding needs.